Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Federal Trade Commission

Generated: April 25, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022070

« Back to Dashboard

NDA 022070 describes ATRALIN, which is a drug marketed by Dow Pharm and is included in one NDA. It is available from three suppliers. Additional details are available on the ATRALIN profile page.

The generic ingredient in ATRALIN is tretinoin. There are twenty-six drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the tretinoin profile page.
Summary for 022070
Applicant:Dow Pharm
Formulation / Manufacturing:see details
Pharmacology for NDA: 022070
Medical Subject Heading (MeSH) Categories for 022070
Suppliers and Packaging for NDA: 022070
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ATRALIN tretinoin GEL;TOPICAL 022070 NDA Coria Laboratories 13548-070 13548-070-45 1 TUBE in 1 PACKAGE (13548-070-45) > 45 g in 1 TUBE
ATRALIN tretinoin GEL;TOPICAL 022070 NDA AUTHORIZED GENERIC Obagi Cosmeceuticals LLC 62032-413 62032-413-20 20 g in 1 TUBE (62032-413-20)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;TOPICALStrength0.05%
Approval Date:Jul 26, 2007TE:ABRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.